| Myasthenia gravis: subgroup classification and therapeutic strategies NE Gilhus, JJ Verschuuren The Lancet Neurology 14 (10), 1023-1036, 2015 | 1042 | 2015 |
| International consensus guidance for management of myasthenia gravis: executive summary DB Sanders, GI Wolfe, M Benatar, A Evoli, NE Gilhus, I Illa, N Kuntz, ... Neurology 87 (4), 419-425, 2016 | 983 | 2016 |
| Screening for tumours in paraneoplastic syndromes: report of an EFNS task force MJ Titulaer, R Soffietti, J Dalmau, NE Gilhus, B Giometto, F Graus, ... European journal of neurology 18 (1), 19-e3, 2011 | 583 | 2011 |
| Über die Myasthenia gravis KE Osserman Klinische Wochenschrift 37 (1), 7-12, 1959 | 559 | 1959 |
| Guidelines for treatment of autoimmune neuromuscular transmission disorders GO Skeie, S Apostolski, A Evoli, NE Gilhus, I Illa, L Harms, D Hilton‐Jones, ... European journal of neurology 17 (7), 893-902, 2010 | 535 | 2010 |
| Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendations 2004 M Brainin, M Barnes, JC Baron, NE Gilhus, R Hughes, K Selmaj, ... European journal of neurology 11 (9), 577-581, 2004 | 488 | 2004 |
| Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force F Deisenhammer, A Bartos, R Egg, NE Gilhus, G Giovannoni, S Rauer, ... European journal of neurology 13 (9), 913-922, 2006 | 402 | 2006 |
| EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of … I Elovaara, S Apostolski, P Van Doorn, NE Gilhus, A Hietaharju, ... European Journal of Neurology 15 (9), 893-908, 2008 | 380 | 2008 |
| International consensus guidance for management of myasthenia gravis: 2020 update P Narayanaswami, DB Sanders, G Wolfe, M Benatar, G Cea, A Evoli, ... Neurology 96 (3), 114-122, 2021 | 376 | 2021 |
| Myasthenia gravis—autoantibody characteristics and their implications for therapy NE Gilhus, GO Skeie, F Romi, K Lazaridis, P Zisimopoulou, S Tzartos Nature reviews neurology 12 (5), 259-268, 2016 | 357 | 2016 |
| EEG background activity described by a large computerized database H Aurlien, IO Gjerde, JH Aarseth, G Eldøen, B Karlsen, H Skeidsvoll, ... Clinical Neurophysiology 115 (3), 665-673, 2004 | 237 | 2004 |
| Subcutaneous sumatriptan during the migraine aura D Bates, E Ashford, R Dawson, FBM Ensink, NE Gilhus, J Olesen, ... Neurology 44 (9), 1587-1587, 1994 | 237 | 1994 |
| Guidelines for the treatment of autoimmune neuromuscular transmission disorders GO Skeie, S Apostolski, A Evoli, NE Gilhus, IK Hart, L Harms, ... European journal of neurology 13 (7), 691-699, 2006 | 228 | 2006 |
| Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy G Veiby, AK Daltveit, BA Engelsen, NE Gilhus Journal of neurology 261, 579-588, 2014 | 226 | 2014 |
| Striational antibodies in myasthenia gravis: reactivity and possible clinical significance F Romi, GO Skeie, NE Gilhus, JA Aarli Archives of Neurology 62 (3), 442-446, 2005 | 213 | 2005 |
| EFNS guideline on diagnosis and management of post‐polio syndrome. Report of an EFNS task force E Farbu, NE Gilhus, MP Barnes, K Borg, M De Visser, A Driessen, ... European Journal of Neurology 13 (8), 795-801, 2006 | 207 | 2006 |
| Pregnancy, delivery, and birth outcome in women with multiple sclerosis J Dahl, KM Myhr, AK Daltveit, JM Hoff, NE Gilhus Neurology 65 (12), 1961-1963, 2005 | 197 | 2005 |
| Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin M Gautel, A Lakey, DP Barlow, Z Holmes, S Scales, K Leonard, S Labeit, ... Neurology 43 (8), 1581-1581, 1993 | 193 | 1993 |
| EFNS/ENS Guidelines for the treatment of ocular myasthenia E Kerty, A Elsais, Z Argov, A Evoli, NE Gilhus European journal of neurology 21 (5), 687-693, 2014 | 191 | 2014 |
| Muscle autoantibodies in subgroups of myasthenia gravis patients F Romi, GO Skeie, JA Aarli, NE Gilhus Journal of neurology 247, 369-375, 2000 | 186 | 2000 |
